Spinelli Lavinia, Martini Stefania, Solla Salvatore Dario, Vigna Taglianti Riccardo, Olivero Francesco, Gianello Luca, Reali Alessia, Merlotti Anna Maria, Franco Pierfrancesco
Radiation Oncology Department, Santa Croce and Carle Hospital, 12100 Cuneo, Italy.
Radiation Oncology Department, Michele and Pietro Ferrero Hospital, 12060 Verduno, Italy.
Cancers (Basel). 2023 Dec 14;15(24):5833. doi: 10.3390/cancers15245833.
Distinction between anal canal and perianal squamous cell carcinomas (pSCCs) is essential, as these two subgroups have different anatomical, histological, and lymphatic drainage features. Early-stage true perianal tumors are very uncommon and have been rarely included in clinical trials. Perianal skin cancers and aCCs are included in the same tumor classification, even though they have different lymphatic drainage features. Furthermore, pSCCs are treated similarly to carcinomas originating from the anal canal. Radiation therapy (RT) is an essential treatment for anal canal tumors. Guidelines do not differentiate between treatment volumes for perianal tumors and anal cancers. So far, in pSCC, no study has considered modulating treatment volume selection according to the stage of the disease. We conducted a narrative literature review to describe the sites at higher risk for microscopic disease in patients with early-stage perianal cancers (T1-T2 N0 M0) to propose a well-thought selection of RT elective volumes.
区分肛管癌和肛周鳞状细胞癌(pSCC)至关重要,因为这两个亚组具有不同的解剖学、组织学和淋巴引流特征。早期真正的肛周肿瘤非常罕见,很少被纳入临床试验。肛周皮肤癌和肛管癌被纳入同一肿瘤分类,尽管它们具有不同的淋巴引流特征。此外,pSCC的治疗方式与源自肛管的癌相似。放射治疗(RT)是肛管肿瘤的重要治疗方法。指南未区分肛周肿瘤和肛管癌的治疗体积。到目前为止,在pSCC中,尚无研究考虑根据疾病分期调整治疗体积的选择。我们进行了一项叙述性文献综述,以描述早期肛周癌(T1-T2 N0 M0)患者微观疾病风险较高的部位,从而提出经过深思熟虑的RT选择性体积选择。